Market Analysis - COPD 2017
COPD 2017 conference is a three-day programme of presentations, panel discussions and interactive dialogue on leading the way in the COPD research development, which will be held during 29-31,May,2017 in Osaka, Japan.The event brings together Professors, researchers,key officials and delegates from almost 50 countries with interactive talks,sessions,workshops and symposiums in the current recent advancements in COPD strategies.
Importance & Scope:
Chronic obstructive pulmonary disease (COPD) is an important public health issue in many countries which is estimated to become the fifth cause of disability and the third cause of mortality in the world within 2020. This landmark study forms an additional foundation for the early history of smoking in order to identify abnormality and risk of progressive impairment on the pathway to symptomatic COPD.
Osaka is a designated city in the Kansai region of Japan. It is the capital city of Osaka Prefecture and the largest component of the Keihanshin Metropolitan Area, the second largest metropolitan area in Japan and among the largest in the world with over 19 million inhabitants. OOsaka has started to garner more attention from foreigners with the increased popularity of cooking and dining in popular culture.
Major COPD Research Associations around Globe
American Association for Respiratory Care
American College of Chest Physicians
American College of Emergency Physicians
American College of Physicians
American Lung Association
Canadian Lung Association (CLA)
Major COPD Research Associations around Asia Pacific
COPD Patient Organization of Vietnam
COPD Patients Club Kyrgyzstan
COPD Club of Northern Thailand
Asian Pacific Society of Respirology
Chinese COPD Patient Education Organziation
Major Universities on COPD Research
Kumamoto University, Japan
Tokyo National Hospital,Japan
Medi7 Bentleigh, Australia
Macquarie University, Australia
Australian national university, Australia
Charles Darwin University Casoria Australia
Curtin University Bentley, Australia
Dar Al Uloom University, Saudi Arabia
Iqbal Chest Centre, Bangladesh
Imperial College London, United Kingdom
Linnaeus University, Sweden
University Of California Los Angeles, United States
Columbia University Medical Center, United States
Harvard University, United States
Global Market research on COPD
The global COPD market is estimated to currently be worth $11.3 billion, and is forecast to reach a value of $15.6 billion by 2019. The drugs driving this growth include once-daily LABA/LAMA fixed-dose combinations such as QVA-149, umeclidinium bromide/vilanterol and olodaterol/tiotropium.
The opportunity in the U.S. and China asthma and COPD drugs market is slated to rise from a valuation of US$13.0 bn in 2015 to be worth US$18.7 bn by 2024. If these values hold true, the market is likely to expand at a modest CAGR of 4.1% therein.
North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
The current asthma and COPD market is primarily driven by increasing patient population. It is also growing due to factors such as price erosion and expiry of patents of leading drug brands in the market. However, it is estimated that in the next five years, the global asthma and COPD drug market is expected to grow slowly and steadfast. The COPD segment was projected to be worth USD 10,593.2 million and is expected to reach USD 12,619.8 million in 2017.
In Europe, LABA / ICS combinations and LTA (Montelukast) drugs are more popular for asthma and COPD treatment.
TOP FACTORS IMPACTING GLOBAL COPD AND ASTHMA DEVICES MARKET
Top few companies in this global market:
F. Hoffmann-La Roche
Novartis and Merck
Global COPD & Asthma Devices Market, By Product
Inhalers accounted for the major market and is expected to continue its dominance till 2020
Global COPD & Asthma Devices Market, By Geography
LAMEA region would exhibit the highest CAGR of 4.9% during 2017-2020